ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
Alexi1
|
1.0K |
279K |
0 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
1.0K
|
279K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
Alexi1
|
1.0K |
279K |
0 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
1.0K
|
279K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
Alexi1
|
1.0K |
279K |
4 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
1.0K
|
279K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
Alexi1
|
1.0K |
279K |
4 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
1.0K
|
279K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB - A Question of Trust?
|
|
Alexi1
|
297 |
71K |
1 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
297
|
71K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB - A Question of Trust?
|
|
Alexi1
|
297 |
71K |
1 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
297
|
71K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
Alexi1
|
982 |
285K |
2 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
982
|
285K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
Alexi1
|
982 |
285K |
4 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
982
|
285K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
Alexi1
|
982 |
285K |
1 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
982
|
285K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
Alexi1
|
982 |
285K |
2 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
982
|
285K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
Alexi1
|
982 |
285K |
4 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
982
|
285K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
Alexi1
|
982 |
285K |
0 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
982
|
285K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast and Lung Disease
|
|
Alexi1
|
37 |
12K |
2 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
37
|
12K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast and Lung Disease
|
|
Alexi1
|
37 |
12K |
0 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
37
|
12K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast and Lung Disease
|
|
Alexi1
|
37 |
12K |
3 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
37
|
12K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Alexi1
|
23K |
13M |
0 |
31/05/20 |
31/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
FDA Expediting Accelerated Development of Novel Therapies for COVID-19
|
|
Alexi1
|
17 |
8.0K |
2 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
17
|
8.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
FDA Expediting Accelerated Development of Novel Therapies for COVID-19
|
|
Alexi1
|
17 |
8.0K |
3 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
17
|
8.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESOBLAST - GVHD - A BIRD IN THE HAND
|
|
Alexi1
|
53 |
37K |
2 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
53
|
37K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESOBLAST - GVHD - A BIRD IN THE HAND
|
|
Alexi1
|
53 |
37K |
7 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
53
|
37K
|
7
|
|